Extract from the Register of European Patents

EP About this file: EP3236990

EP3236990 - LIQUID PHARMACEUTICAL COMPOSITION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.07.2021
Database last updated on 31.03.2026
FormerThe patent has been granted
Status updated on  31.07.2020
FormerGrant of patent is intended
Status updated on  15.01.2020
FormerRequest for examination was made
Status updated on  29.09.2017
FormerThe international publication has been made
Status updated on  15.06.2017
Most recent event   Tooltip16.06.2023Lapse of the patent in a contracting state
New state(s): NL
published on 19.07.2023  [2023/29]
Applicant(s)For all designated states
Ares Trading S.A.
Zone Industrielle de l'Ouriettaz
1170 Aubonne / CH
[2017/44]
Inventor(s)01 / FREITAG, Angelika
Coriolis Pharma Biopharmaceutical Research and
Development Service
Am Kloperferspitz
1982152 Martinsried / DE
02 / HAWE, Andrea
Coriolis Pharma Biopharmaceutical Research and
Development Service
Am Kloperferspitz
1982152 Martinsried / DE
03 / RINALDI, Gianluca
Via Gino Silvestrini 9
00015 Monterotondo (RM) / IT
04 / DEL RIO, Alessandra
Via IIdebrando Vivanti 108
00144 Roma / IT
 [2017/44]
Representative(s)Merck Serono S.A. Intellectual Property
Terre Bonne Business Park
Building Z0
Route de Crassier 1
1262 Eysins / CH
[2020/36]
Former [2017/44]Merck Serono S.A. Intellectual Property
Zone Industrielle de l'Ouriettaz
1170 Aubonne / CH
Application number, filing date15813418.917.12.2015
[2017/44]
WO2015EP80326
Priority number, dateEP2014019987122.12.2014         Original published format: EP 14199871
[2017/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016102328
Date:30.06.2016
Language:EN
[2016/26]
Type: A1 Application with search report 
No.:EP3236990
Date:01.11.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 30.06.2016 takes the place of the publication of the European patent application.
[2017/44]
Type: B1 Patent specification 
No.:EP3236990
Date:02.09.2020
Language:EN
[2020/36]
Search report(s)International search report - published on:EP30.06.2016
ClassificationIPC:A61K38/17, A61K47/18, A61K47/26, A61K9/08
[2017/44]
CPC:
A61K9/0019 (EP,CN,IL,US); A61K9/08 (EP,CN,IL,US); A61K38/1793 (EP,CN,IL,US);
A61K47/06 (IL,US); A61K47/18 (IL,US); A61K47/183 (EP,CN,IL,US);
A61K47/26 (EP,CN,IL,US); A61P17/06 (EP,IL); A61P19/00 (EP,IL);
A61P19/02 (EP,IL); A61P19/06 (EP,IL); A61P29/00 (EP,IL);
C07K14/70578 (US); C07K14/7151 (US); C07K19/00 (US);
C07K2319/03 (US); C07K2319/30 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/44]
Extension statesBA14.06.2017
ME14.06.2017
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:FLÜSSIGE PHARMAZEUTISCHE ZUSAMMENSETZUNG[2017/44]
English:LIQUID PHARMACEUTICAL COMPOSITION[2017/44]
French:COMPOSITION PHARMACEUTIQUE LIQUIDE[2017/44]
Entry into regional phase14.06.2017National basic fee paid 
14.06.2017Designation fee(s) paid 
14.06.2017Examination fee paid 
Examination procedure14.06.2017Examination requested  [2017/44]
14.06.2017Date on which the examining division has become responsible
06.02.2018Amendment by applicant (claims and/or description)
16.01.2020Communication of intention to grant the patent
20.03.2020Receipt of the translation of the claim(s)
06.07.2020Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
23.07.2020Fee for grant paid
23.07.2020Fee for publishing/printing paid
Opposition(s)03.06.2021No opposition filed within time limit [2021/32]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
23.07.2020Request for further processing filed
23.07.2020Full payment received (date of receipt of payment)
Request granted
04.08.2020Decision despatched
Fees paidRenewal fee
12.12.2017Renewal fee patent year 03
12.12.2018Renewal fee patent year 04
13.12.2019Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.12.2015
AL02.09.2020
AT02.09.2020
CY02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
MK02.09.2020
MT02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
TR02.09.2020
NL23.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IE17.12.2020
LU17.12.2020
BE31.12.2020
IS02.01.2021
PT04.01.2021
[2023/29]
Former [2022/34]HU17.12.2015
AL02.09.2020
AT02.09.2020
CY02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
MK02.09.2020
MT02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
TR02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IE17.12.2020
LU17.12.2020
BE31.12.2020
IS02.01.2021
PT04.01.2021
Former [2022/32]HU17.12.2015
AL02.09.2020
AT02.09.2020
CY02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
MK02.09.2020
MT02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
TR02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IE17.12.2020
LU17.12.2020
IS02.01.2021
PT04.01.2021
Former [2022/27]HU17.12.2015
AL02.09.2020
AT02.09.2020
CY02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
MT02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
TR02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IE17.12.2020
LU17.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/47]AL02.09.2020
AT02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IE17.12.2020
LU17.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/46]AL02.09.2020
AT02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IE17.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/40]AL02.09.2020
AT02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/37]AL02.09.2020
AT02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/36]AL02.09.2020
AT02.09.2020
CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/28]AL02.09.2020
AT02.09.2020
CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/25]AL02.09.2020
AT02.09.2020
CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/23]AT02.09.2020
CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
PT04.01.2021
Former [2021/22]CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
PT04.01.2021
Former [2021/21]FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RS02.09.2020
SE02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
PT04.01.2021
Former [2021/10]FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RS02.09.2020
SE02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
Former [2021/09]FI02.09.2020
LT02.09.2020
SE02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
Former [2021/08]FI02.09.2020
LT02.09.2020
SE02.09.2020
BG02.12.2020
NO02.12.2020
Former [2021/07]FI02.09.2020
LT02.09.2020
NO02.12.2020
Cited inInternational search[X] WO2012165917  (LG LIFE SCIENCES LTD et al.)
 [X] WO2012143418  (SANDOZ AG et al.)
 [X] US2013101584  (MANNING MARK et al.)
 [XD] WO2011141926  (INTAS BIOPHARMACEUTICALS LTD et al.)
 [X] WO2014178216  (NIPRO CORP et al.)
 [XD] WO2013006454  (BIOGEN IDEC INC et al.)
by applicantWO9103553
 WO9406476
 US5605690
 WO03072060
 WO2011141926
 WO2012165914
 WO2013006454
 US7276477
   B. GOFFE; J. C. CATHER, J. AM. ACAD. DERMATOL., vol. 49, 2003, pages S105 - S111
   S. NANDA; J. M. BATHON, EXPERT OPIN. PHARMACOTHER, vol. 5, 2004, pages 1175 - 1186
   PENNICA, D. ET AL., NATURE, vol. 312, 1984, pages 724 - 729
   DAVIS, J. M. ET AL., BIOCHEMISTRY, vol. 26, 1987, pages 1322 - 1326
   JONES, E. Y. ET AL., NATURE, vol. 338, 1989, pages 225 - 228
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.